DES ACTION USA IS IN COLLABORATION WITH THE MEDSHADOW FOUNDATION. CLICK HERE TO LEARN MORE.

About DES (Diethylstilbestrol): DES and Cancer

Navigating the Complex Landscape of Cancer Risks: In-Depth Insights into DES and Breast, Cervical, Testicular, and Prostate Cancers"

Breast Cancer

Breast cancer has many risk factors, and DES exposure is one of them. Previous studies have shown a small increase in risk among DES Daughters throughout their lifetime. However, in the latest analysis by the National Cancer Institute, there was up to a 30% increase in breast cancer risk in DES Daughters in their 40s. The excess risk appears to begin lessening after age 50, even though breast cancer risk in general – independent of DES exposure – tends to increase with age. Please see the most recent study. Members may log in to read our report on this study in the Winter Voice 2018. The breast cancer risk for DES Mothers is approximately 30% higher (considered moderately higher) than for women not given DES during pregnancy.

As a result, DES Action USA encourages DES Mothers and DES Daughters to remind their healthcare providers of their increased breast cancer risk and discuss an appropriate screening regimen. For most, it means annual mammograms coupled with annual clinical breast exams. Also, all women should pay attention to their breasts and alert their doctors if any changes are noticed.

Read earlier background information from a 2006 study showing increased breast cancer rates for DES Daughters that showed even higher risk for DES Daughters aged 50 and older. Click here for the Journal article describing the 2006 study. However, the 2017 journal article changed that to attenuated risk for DES Daughters age 50 and older, even though breast cancer risk in general – independent of DES exposure – tends to increase with age.

Of note is that no specific tumor type or gene mutation has been associated with DES Daughter breast cancer. Rather, it is suspected by researchers that prenatal DES exposure may increase the growth of any cells that develop into breast cancer. It is this potential for a more rapid growth rate that results in the increased risk for, and incidence of, breast cancer at an earlier age for DES Daughters.

The additional breast cancer risk for DES Daughters should be considered in decisions regarding hormone replacement therapy. When absolutely necessary, only the lowest dose of HRT should be used for only a short period should be considered. This recommendation applies to all women, especially DES Daughters and DES Mothers.

An interesting question being examined by researchers with the National Cancer Institute DES Follow-up Study is whether bra cup sizes may help explain the DES Daughter link to breast cancer. The thinking is that prenatal DES exposure may increase mammary gland cell formation – hence larger bra cups. An initial study found support for the hypothesis that in utero, DES exposure may result in greater mammary mass, which is believed to raise the risk for breast cancer.

 

Clear Cell Adenocarcinoma (CCA) of the Vagina and Cervix

The risk is small, estimated at 1 in 1,000 for this rare cancer. It was once thought DES Daughters over age 30 were no longer at risk, but we now know CCA is a lifelong concern. Cases have been reported in Daughters older than 50, when CCA may also occur in the unexposed population. Researchers are now watching for a possible spike in cases of post-menopausal DES Daughters. A population-based analysis by CDC researchers suggests an elevated CCA risk for DES Daughters as they age. Studies are underway, but at this point, there does not appear to be an upper age limit for this cancer in DES Daughters.

  • Cervical Cancer Vaccine
    The cervical cancer vaccine that is now available does NOT protect against the type of cancer linked to DES exposure, which is clear cell adenocarcinoma (CCA) of the cervix and vagina. What the vaccine does is provide protection against the more common types of cervical cancer and genital warts that are caused by the Human Papillomavirus (HPV).

 

Testicular Cancer (Possible)

No DES-specific testicular cancer has been found; however, research shows that congenital abnormalities such as undescended testicles predispose men to testicular cancer. Therefore, DES Sons and DES Grandsons, with a higher rate of such urogenital anomalies, might be considered a high-risk group. All men should practice testicular self-exam and do so regularly.

 

Prostate Cancer (Possible)

DES Sons are reaching or are in the age when prostate cancer may occur, but there have not been reports of an increased incidence of prostate cancer in DES Sons. That said, animal studies point to the possibility of a heightened risk for DES-exposed men, leading some researchers to speculate that DES Sons could be at higher risk and should pay attention to the possibility.